These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8477883)

  • 41. Increased transcapillary escape rate of albumin in type 1 (insulin-dependent) diabetic patients with microalbuminuria.
    Feldt-Rasmussen B
    Diabetologia; 1986 May; 29(5):282-6. PubMed ID: 3522326
    [TBL] [Abstract][Full Text] [Related]  

  • 42. von Willebrand factor antigen in plasma and urine in patients with type I (insulin-dependent) diabetes mellitus with and without nephropathy.
    Silveira AM; Sjöberg S; Blombäck M; Ostman J
    J Diabetes Complications; 1992; 6(2):89-95. PubMed ID: 1611144
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased capillary filtration of albumin in diabetic patients--relation with gender, hypertension, microangiopathy, and neuropathy.
    Valensi P; Behar A; Attalah M; Cohen-Boulakia F; Pariès J; Attali JR
    Metabolism; 1998 May; 47(5):503-7. PubMed ID: 9591738
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Electrical charge of serum and urinary albumin in normal and diabetic humans.
    Ghiggeri GM; Candiano G; Delfino G; Queirolo C
    Kidney Int; 1985 Aug; 28(2):168-77. PubMed ID: 3834228
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Implications for glucose measures in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.
    Whaley-Connell A; Sowers JR
    Diabetes; 2014 Jan; 63(1):45-7. PubMed ID: 24357694
    [No Abstract]   [Full Text] [Related]  

  • 46. Sodium-lithium countertransport is increased in normoalbuminuric type 1 diabetes but is not related to other risk factors for microangiopathy.
    Vervoort G; Elving LD; Wetzels JF; Lutterman JA; Smits P; de Pont JJ; Berden JH
    Eur J Clin Invest; 2002 Feb; 32(2):93-9. PubMed ID: 11895455
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Variability in glycated albumin levels predicts the progression of diabetic nephropathy.
    Park SB; Kim SS; Kim IJ; Nam YJ; Ahn KH; Kim JH; Jeon YK; Kim BH; Song SH; Kwak IS; Lee EK; Kim YK
    J Diabetes Complications; 2017 Jun; 31(6):1041-1046. PubMed ID: 28396158
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Leucocyte Na+/H+ antiport activity in type 1 (insulin-dependent) diabetic patients with nephropathy.
    Ng LL; Simmons D; Frighi V; Garrido MC; Bomford J; Hockaday TD
    Diabetologia; 1990 Jun; 33(6):371-7. PubMed ID: 2165946
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Urinary connective tissue growth factor excretion in patients with type 1 diabetes and nephropathy.
    Gilbert RE; Akdeniz A; Weitz S; Usinger WR; Molineaux C; Jones SE; Langham RG; Jerums G
    Diabetes Care; 2003 Sep; 26(9):2632-6. PubMed ID: 12941731
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Damage of charge-dependent renal tubular reabsorption causes diabetic microproteinuria.
    Kunika K; Yamaoka T; Itakura M
    Diabetes Res Clin Pract; 1997 Apr; 36(1):1-9. PubMed ID: 9187409
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of glycaemic control in development of microalbuminuria in patients with insulin dependent diabetes.
    Powrie JK; Watts GF; Ingham JN; Taub NA; Talmud PJ; Shaw KM
    BMJ; 1994 Dec; 309(6969):1608-12. PubMed ID: 7819935
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evidence linking glycated albumin to altered glomerular nephrin and VEGF expression, proteinuria, and diabetic nephropathy.
    Cohen MP; Chen S; Ziyadeh FN; Shea E; Hud EA; Lautenslager GT; Shearman CW
    Kidney Int; 2005 Oct; 68(4):1554-61. PubMed ID: 16164632
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reactivity with diazonium salts of albumin from micro and macroalbuminuric diabetic patients.
    Ghiggeri GM; Candiano G; Delfino G; Queirolo C
    Diabete Metab; 1987 Feb; 13(1):58-62. PubMed ID: 3569634
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serum albumin-adjusted glycated albumin reflects glycemic excursion in diabetic patients with severe chronic kidney disease not treated with dialysis.
    Fukami K; Shibata R; Nakayama H; Yamada K; Okuda S; Koga M
    J Diabetes Complications; 2015; 29(7):913-7. PubMed ID: 26164356
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Glycated albumin and the risk of micro- and macrovascular complications in subjects with type 1 diabetes.
    Yoon HJ; Lee YH; Kim SR; Rim TH; Lee EY; Kang ES; Cha BS; Lee HC; Lee BW
    Cardiovasc Diabetol; 2015 May; 14():53. PubMed ID: 25975731
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasma cholesteryl ester transfer protein and its relationship to plasma lipoproteins and apolipoprotein A-I-containing lipoproteins in IDDM patients with microalbuminuria and clinical nephropathy.
    Kahri J; Groop PH; Elliott T; Viberti G; Taskinen MR
    Diabetes Care; 1994 May; 17(5):412-9. PubMed ID: 8062608
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Altered transcapillary escape of albumin and microalbuminuria reflects two different pathogenetic mechanisms.
    Nosadini R; Velussi M; Brocco E; Abaterusso C; Piarulli F; Morgia G; Satta A; Faedda R; Abhyankar A; Luthman H; Tonolo G
    Diabetes; 2005 Jan; 54(1):228-33. PubMed ID: 15616033
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Significance of variation in turnover of glycated albumin on indices of diabetic control.
    Johnson RN; Easdale RW; Tatnell M; Baker JR
    Clin Chim Acta; 1991 May; 198(3):229-38. PubMed ID: 1889123
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The clinical usefulness of glycated albumin in patients with diabetes and chronic kidney disease: Progress and challenges.
    Gan T; Liao B; Xu G
    J Diabetes Complications; 2018 Sep; 32(9):876-884. PubMed ID: 30049445
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multiple lipoprotein abnormalities in type I diabetic patients with renal disease.
    Groop PH; Elliott T; Ekstrand A; Franssila-Kallunki A; Friedman R; Viberti GC; Taskinen MR
    Diabetes; 1996 Jul; 45(7):974-9. PubMed ID: 8666151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.